HCPCS Code Descriptor:
Injection, pembrolizumab, 1 mg
Route of Administration:
KEYTRUDA is an Oncology drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J9271 is aligned to the drug KEYTRUDA.
Keytruda is a cancer drug that is used to treat numerous types of cancer and can be used by itself or with other cancer medications. This medication works by stopping the growth of the cancer cells. Keytruda is administered by infusion into the vein over the course of at least thirty minutes. Keytruda is manufactured by Merck Sharp & Dohme Corporation and is a branded drug. Patient assist programs for Keytruda can be found through Merck.